本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Immunovant, Inc.

16.29
-0.4800-2.86%
盘后16.290.00000.00%18:38 EDT
成交量:105.79万
成交额:1,727.68万
市值:27.84亿
市盈率:-5.97
高:17.15
开:17.08
低:15.95
收:16.77
数据加载中...
2020/04/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/04/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/08

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2020/04/03

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/03/30

重要事件披露

8-K - Current report
2020/02/28

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/28

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/02/26

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/02/19

重要事件披露

Current report, item 5.02
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/02/14

重要事件披露

Current report, items 2.02 and 9.01
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/17

招股说明书

General form for registration of securities under the Securities Act of 1933
2019/12/27

超过5%披露

General statement of acquisition of beneficial ownership
2019/12/20

超过5%披露

General statement of acquisition of beneficial ownership
2019/12/20

重要事件披露

Current report, items 1.01, 2.01, 2.02, 3.02, 3.03, 4.01, 5.01, 5.02, and 9.01
2019/12/17

重要事件披露

Current report, item 5.07